Skip to main content
Walter Curran, MD, Radiation Oncology, Atlanta, GA

WalterJ.CurranMD

Radiation Oncology Atlanta, GA

Global Chief Medical Officer, GenesisCare

Dr. Curran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Curran's full profile

Already have an account?

  • Office

    1800 Howell Mill Rd NW Ste 300
    Atlanta, GA 30318
    Phone+1 404-425-1777
    Fax+1 404-778-5152

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Radiation Oncology, 1983 - 1986
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1982 - 1983
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 1982

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2008 - 2025
  • PA State Medical License
    PA State Medical License 1983 - 2008
  • American Board of Radiology Radiation Oncology
  • American Board of Radiology Therapeutic Radiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Learning‐Based CBCT Correction Using Alternating Random Forest Based on Auto‐Context Model  
    Robert Press, Tian Liu, Walter J Curran, Jolinta Lin, Kristin Higgins, Medical Physics
  • T Cell Receptor Sequencing of Activated CD8 T Cells in the Blood Identifies Tumor-Infiltrating Clones That Expand After PD-1 Therapy and Radiation in a Melanoma Patient  
    Jonathan J Masor, Juan Sarmiento, Walter J Curran, David H Lawson, Rafi Ahmed, Yue Xue, Cancer Immunology, Immunotherapy
  • Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with Radiotherapy  
    Gabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer
  • Join now to see all

Authored Content

  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018

Press Mentions

  • Abstract Session Highlights Important Supportive, Palliative Care Research
    Abstract Session Highlights Important Supportive, Palliative Care ResearchAugust 8th, 2022
  • Walter Curran, MD, on Integration of Immunotherapy with Radiation Therapy
    Walter Curran, MD, on Integration of Immunotherapy with Radiation TherapyFebruary 22nd, 2020
  • A Randomized Phase III Study of Accelerated Hyperfractionation Versus Standard in Patients with Unresected Brain Metastases: A Report of the Radiation Therapy Oncology Group (RTOG) 9104
    A Randomized Phase III Study of Accelerated Hyperfractionation Versus Standard in Patients with Unresected Brain Metastases: A Report of the Radiation Therapy Oncology Group (RTOG) 9104October 1st, 2019
  • Join now to see all

Grant Support

  • Radiation Therapy Oncology GroupNational Cancer Institute1987–2012
  • RTOG Biospecimen RepositoryNational Cancer Institute2011
  • Emory Winship Cancer Institute Cancer Center Support GrantNational Cancer Institute2009–2011
  • Towards A Refined Molecular Recursive Partitioning Analysis Model For GlioblastomNational Cancer Institute2009–2010
  • RTOG Tissue BankNational Cancer Institute2005–2010
  • Community Clinical Oncology Program Research BaseNational Cancer Institute1987–2010
  • RTOG CCOP Research Base - Foreign AccrualNational Cancer Institute2006
  • Foreign Accrual For RTOG 5u10ca02166 2006 LoadNational Cancer Institute2006
  • RTOG - Foreign AccrualNational Cancer Institute2005
  • Community Clinical Oncology Research Base - Foreign AccrualNational Cancer Institute2005
  • RTOG Foreign AccrualsNational Cancer Institute2004
  • RTOG Foreign AccraulNational Cancer Institute2004
  • Relevance Of Genomic Alterations In Colorectal CancerNational Cancer Institute2000–2004
  • RTOG Foreign AccrualNational Cancer Institute2003
  • Foreign Accrual - RTOGNational Cancer Institute2003
  • Innovative Approaches To Patients With AdenocarcinomaNational Cancer Institute2000–2002
  • Radiation Therapy OncologyNational Cancer Institute1997
  • Community Clinical Oncology Research BaseNational Cancer Institute1994–1997
  • Radiation Therapy Oncology Group (Rtog)--HeadquartersNational Cancer Institute1994–1996
  • 3D CRT In Prostate Cancer--Operations/Statistical CenterNational Cancer Institute1993–1996
  • Breast Cancer Research Program Intergration/FormalizatioNational Cancer Institute1994–1995
  • Radiation Therapy Oncology Group (RTOG) HeadquartersNational Cancer Institute1994
  • Breast Cancer Research Program Intergration/FormalizatioNational Cancer Institute1994
  • Radiation Therapy Oncology Group-Rtog-HeadquartersNational Cancer Institute1992–1993
  • Community Clinical Oncology ProgramNational Cancer Institute1988–1990
  • Radiation Therapy Oncology Group (H/P)National Cancer Institute1989

Committees

  • Member, Definitive and Adjuvant Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Guideline Panel, American Society for Radiation Oncology 2015 - Present

Professional Memberships